HR6986-118

Introduced

To address patent thickets.

118th Congress Introduced Jan 12, 2024

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To address patent thickets., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Trade, Agriculture.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H3735BDC66FEE4F0E9F53302758DE3226: 1. Addressing patent thickets Section 271(e) of title 35, United States Code, is amended by adding at the end the following: (7)(A)A person who brings an...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To address patent thickets., changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Trade, Agriculture

Primary Purpose

This bill, To address patent thickets., changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Trade Agriculture

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
health care providers and patients:
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies:
health care providers and patients:

Legislative Progress

Introduced
Introduced Committee Passed
Jan 12, 2024

Mr. Arrington (for himself, Mr. Pfluger, Mr. Issa, Mr. Doggett, …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Trade Agriculture
Actor Mappings
"federal_implementing_agencies"
→ Federal agencies assigned duties by the bill

Key Definitions

Terms defined in this bill

1 term
"Patent Group" §H3735BDC66FEE4F0E9F53302758DE3226

2 or more commonly owned patents or applications that— are identified on 1 or more disclaimers under section 253 to obviate obviousness-type double patenting of another commonly owned patent

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology